Comparative Effectiveness Research
Showing 1 - 25 of >10,000
Unresectable Pleural Mesothelioma Trial in Worldwide (Volrustomig, Pemetrexed, Carboplatin)
Not yet recruiting
- Unresectable Pleural Mesothelioma
- Volrustomig
- +5 more
-
Duarte, California
- +133 more
Oct 18, 2023
Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)
Not yet recruiting
- Metastatic Castration-Sensitive Prostate Cancer
- AZD5305
- +4 more
-
Tucson, Arizona
- +192 more
Nov 6, 2023
Locally Advanced Cervical Cancer Trial in Worldwide (Volrustomig, Placebo)
Recruiting
- Locally Advanced Cervical Cancer
- Volrustomig
- Placebo
-
Savannah, Georgia
- +85 more
Oct 6, 2023
Chronic Kidney Disease With High Proteinuria Trial in Worldwide (Zibotentan/Dapagliflozin, Dapagliflozin)
Not yet recruiting
- Chronic Kidney Disease With High Proteinuria
-
Bakersfield, California
- +99 more
Oct 17, 2023
Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)
Not yet recruiting
- Biliary Tract Cancer
- Rilvegostomig
- +4 more
-
Clayton, Australia
- +65 more
Oct 26, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (volrustomig)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
-
Prescott Valley, Arizona
- +71 more
Nov 10, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in China
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Hefei, Anhui, China
- +23 more
Nov 23, 2023
Identify and Characterise Chronic Kidney Disease and Proteinuria
Not yet recruiting
- Renal Disease
- assessment
-
Bakersfield, California
- +87 more
Jul 20, 2023
Uncontrolled Hypertension, Resistant Hypertension Trial in Worldwide (Baxdrostat, Placebo)
Not yet recruiting
- Uncontrolled Hypertension
- Resistant Hypertension
- Baxdrostat
- Placebo
-
Saraland, Alabama
- +122 more
Sep 6, 2023
B-cell Acute Lymphoblastic Leukemia (B-ALL) Trial in Worldwide (AZD0486)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
-
Duarte, California
- +30 more
Nov 13, 2023
Research Participation With Transgender and Gender-Diverse Youth
Not yet recruiting
- Transgender Persons
- Survey
- (no location specified)
Jun 21, 2023
Stroke Research Initiative to Advance Equity
Not yet recruiting
- Stroke
- (no location specified)
Oct 4, 2023
Asthma Trial in Worldwide (Tezepelumab, Placebo)
Recruiting
- Asthma
- Tezepelumab
- Placebo
-
Montgomery, Alabama
- +38 more
Aug 30, 2023
Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open
Not yet recruiting
- Systemic Sclerosis
- Scleroderma
- Anifrolumab (blinded)
- +2 more
-
Birmingham, Alabama
- +130 more
Jun 22, 2023
HER2-low Unresectable and/or Metastatic Breast Cancer in Russia
Recruiting
- Breast Cancer
-
Arkhangelsk, Russian Federation
- +41 more
Jun 28, 2023
Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)
Not yet recruiting
- Hypophosphatasia
- ALXN1850
- asfotase alfa
-
Hartford, Connecticut
- +29 more
Oct 6, 2023
Rare Cancers, Multiomics Trial in Heidelberg
Recruiting
- Rare Cancers
- Multiomics
-
Heidelberg, GermanyGerman Cancer Research Center
May 2, 2023
COPD (COPD) Trial in Worldwide (Placebo, Tozorakimab)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Placebo
- Tozorakimab
-
Sheffield, Alabama
- +31 more
Sep 11, 2023
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
Recruiting
- Chronic Lymphocytic Leukemia
-
Almeria, Andalucia, Spain
- +36 more
Aug 10, 2023
Hearing Loss Trial in Lone Tree, Melbourne (the Mobile Research App, SOC/validated delivery of the speech perception test
Not yet recruiting
- Hearing Loss
- the Mobile Research App
- SOC/validated delivery of the speech perception test material
-
Lone Tree, Colorado
- +1 more
Oct 19, 2023